KAIST 생명과학과동창회
  • News & Events
  • News

News

Antibiotic tolerance study paves way for new treatments


A new study identifies a mechanism that makes bacteria tolerant to penicillin and related antibiotics, findings that could lead to new therapies that boost the effectiveness of these treatments.


Antibiotic tolerance is the ability of bacteria to survive exposure to antibiotics, in contrast to antibiotic resistance, when bacteria actually grow in the presence of antibiotics. Tolerant bacteria can lead to infections that persist after treatment and may develop into resistance over time.

The study in mice, “A Multifaceted Cellular Damage Repair and Prevention Pathway Promotes High Level Tolerance to Beta-lactam Antibiotics,” published Feb. 3 in the journal EMBO Reports, reveals how tolerance occurs, thanks to a system that mitigates iron toxicity in bacteria that have been exposed to penicillin.


“We’re hoping we can design a drug or develop antibiotic adjuvants that would then basically kill off these tolerant cells,” said senior author Tobias Dörr, assistant professor of microbiology in the Weill Institute for Cell and Molecular Biology in the College of Agriculture and Life Sciences.


Co-authors included Ilana Brito, the Mong Family Sesquicentennial Faculty Scholar and assistant professor in the Meinig School of Biomedical Engineering in the College of Engineering, and Lars Westblade, associate professor of pathology and laboratory medicine at Weill Cornell Medicine.


Some bacteria, including the model bacterium used in the study, Vibrio cholerae, which causes cholera in humans, are remarkably tolerant to penicillin and related antibiotics, known as beta lactam antibiotics. It has been known for a long time that beta-lactam antibiotics break down bacterial cell walls, but how bacteria survive loss of their cell walls was poorly understood.


In the study, the researchers developed a V. cholerae mutant that lacked a two-component damage repair response system that controls a gene network encoding diverse functions. Without the system, known as VxrAB, when the cell wall is damaged by antibiotics, the transfer of electrons across the cell membrane goes awry, leading to electrons ending up on the wrong molecules. This misdirection causes hydrogen peroxide to accumulate in the cell, which changes the oxidation state of cellular iron and disrupts signals for the cell to tell how much iron it has.   


In the presence of hydrogen peroxide, the mutant bacteria cannot sense how much iron has been acquired, and it behaves as if it is iron-starved and seeks to acquire more iron. Left unchecked, these circumstances cause iron toxicity, which will kill the cell, according to the experiments the researchers conducted. In further tests with mutant V. cholerae bacteria, both in test tubes and in mice, the researchers showed that reducing the influx of iron increased the bacteria’s tolerance to beta lactams.


Fortunately for normal V. cholerae, exposure to antibiotics and the breakdown of the cell’s walls activate the VxrAB system, which works to repair cell walls and downregulates iron uptake systems, and thereby creates antibiotic tolerance. More study is needed to understand what triggers the VxrAB system in the presence of beta-lactam antibiotics.


The research opens the door for developing new drugs that could be combined with antibiotics to exploit oxidative damage and iron influx in tolerant bacteria. In future work, the researchers will search for parallel mechanisms of tolerance in other bacterial pathogens.


Jung-Ho Shin, a postdoctoral researcher in Dörr’s lab, is the paper’s first author. Co-authors include researchers from the Korea Advanced Institute of Science and Technology, the Korea Advanced Institute of Science and Technology, and the Intelligent Synthetic Biology Center in Korea.

The study was funded by the National Research Foundation of Korea and the National Institutes of Health.


https://news.cornell.edu/stories/2021/02/antibiotic-tolerance-study-paves-way-new-treatments

https://www.miragenews.com/antibiotic-tolerance-study-paves-way-for-new-516267/



List of Articles
번호 제목 글쓴이 날짜 조회 수
170 생명과학과 박태관 교수, 두 저널에 표지논문으로 게재 과사무실 2008.06.25 11434
169 생명과학과 박태관 교수, 새로운 항암유전자 전달시스템 개발 과사무실 2008.07.08 15037
168 생명과학과 신임교원 David Helfman 박사 부임 소개 (2009.8.1) 과사무실 2009.09.10 12098
167 생명과학과 신임교원 강석조 박사 소개 (2010.01.01) 과사무실 2009.12.29 16254
166 생명과학과 신임교원 오병하 박사 부임 소개 (2009.9.1) 과사무실 2009.09.10 14202
165 생명과학과 신임교원 한진희 박사 소개 (2009.10.01) 과사무실 2009.10.06 16347
164 생명과학과 신임교원 허원도 박사 부임 예정 과사무실 2007.10.16 15146
163 생명과학과 이문수 박사(이노테라피 CEO) 지혈제로 240억 '주식 갑부' file 생명과학과 2019.02.07 6652
162 생명과학과 최길주 교수, 빛 없이 싹틔우는 유전자 발견 과사무실 2008.05.30 12669
161 생명과학과 출신 곽유상 박사 ... 美 대학교수 됐다 과사무실 2007.07.31 14020
160 서경배재단 ‘올해의 신진 과학자’ 조원기 교수 선정 생명과학과 2020.09.16 4007
159 서라민 박사과정 학생. 제 18차 KHUPO 프로테오믹스 국제학술대회 수상 file 생명과학과 2018.04.30 13690
158 서성배 교수, 당뇨에 큰 영향 미치는 뇌 혈당조절 신경세포 발견 file 생명과학과 2019.10.30 4745
157 서성배 교수, 스트레스 세포(CRF 세포) 변화 초 단위 관찰 성공 file 생명과학과 2019.04.18 7278
156 서성배 교수님(김보람 연수연구원)_제20회 한국 로레알-유네스코 여성과학자상 수상 file 생명과학과 2021.09.27 1194
155 서성배 교수님(김진은 석박사통합과정)_2020 대한민국 인재상 수상 생명과학과 2021.02.25 1839
154 서성배 교수님(양대욱 박사)_세종과학펠로우십 선정 생명과학과 2021.03.18 962
153 서성배 교수님_Gut hormone triggers craving for more proteins 생명과학과 2021.05.18 672
152 서성배 교수님_동물 뇌 신경세포가 과식 억제한다 생명과학과 2021.06.16 635
151 서성배 교수님_동물의 식습관을 조절하는 원리 규명해 네이처 게재​ 생명과학과 2021.05.11 554
Board Pagination Prev 1 ... 9 10 11 12 13 14 15 16 17 18 ... 22 Next
/ 22